Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
doi: 10.1053/j.gastro.2021.12.288
Koch A, et al
One large placebo-controlled trial (presented at the AUA meeting in 2007) tested intranasal bremelanotide in 726 men with ED (average age 55) over 12 weeks
In the models with time-dependent covariates, both cumulative standardized dose and duration during follow-up showed significant protective effects against cirrhosis development (HR and 95%CI=0.72 [0.68, 0.76]) and 0.67 [0.63, 0.72], respectively)
US$ 23.40
&srotate=0)
US$ 23.58
US$ 22.70
US$ 24.67
US$ 24.39
US$ 21.47
US$ 25.89
US$ 21.84
